Viral hepatitis remains the most common cause of liver disease and a major public health problem. Here, we focus on the role of CD4 CD8 double negative T (DN T) cells involved in the mechanisms of viral persistence in hepatitis. C3H/HeJ mice infected with murine hepatitis virus strain 3 (MHV-3) were used to display chronic viral hepatitis. DN T cells dramatically increased in MHV-3 infected mice. Adoptive transfer of DN T cells from MHV-3 infected mice led to a significant increase in mice survival. The DN T cells with production of IFN-gamma and IL-2 are able to kill virus-specific CD8(+) T cells via the Fas/FasL dependent pathway. The delicate balance of multiple effects of DN T cells may lead to viral persistence in MHV-3 induced hepatitis. In short, our study identified DN T cells contributing to viral persistence in MHV-3 induced hepatitis in C3H/HeJ mice, which provides a rationale for modulating DN T cells for the management of viral hepatitis. (C) 2012 Elsevier Inc. All rights reserved.
基金:
National Science Foundation of China [NSFC 81030007, NSFC 81171558, NSFC30972606]; Ministry of Health [439]; Innovative Research Team in University of Ministry of Education [IRT1131]
第一作者单位:[1]Huazhong Univ Sci & Technol,Dept Infect Dis,Tongji Hosp,Tongji Med Coll,Wuhan 430030,Peoples R China[2]Huazhong Univ Sci & Technol,Inst Infect Dis,Tongji Hosp,Tongji Med Coll,Wuhan 430030,Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Wang Xiaojing,Yan Weiming,Lu Yulei,et al.CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation[J].CELLULAR IMMUNOLOGY.2012,280(1):76-84.doi:10.1016/j.cellimm.2012.11.010.
APA:
Wang, Xiaojing,Yan, Weiming,Lu, Yulei,Chen, Tao,Sun, Ying...&Ning, Qin.(2012).CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation.CELLULAR IMMUNOLOGY,280,(1)
MLA:
Wang, Xiaojing,et al."CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation".CELLULAR IMMUNOLOGY 280..1(2012):76-84